| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 04/06/2005 | EP1519757A1 Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 04/06/2005 | EP1519750A2 Oxygenating agents for enhancing host responses to microbial infections |
| 04/06/2005 | EP1519739A2 Natural herbal antibiotic for the treatment of the infections of the upper respiratory system and various diseases in the body |
| 04/06/2005 | EP1218494B1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 04/06/2005 | EP1214084B1 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 04/06/2005 | EP1006964B1 Intrauterine chemical necrosing compositions and apparatus |
| 04/06/2005 | CN1604941A Anti-bacterial composite particles and anti-bacterial resin composition |
| 04/06/2005 | CN1604785A Thermoplastic articles exhibiting high surface-available silver |
| 04/06/2005 | CN1603263A Use of glass compositions for achieving an antioxidative effect |
| 04/06/2005 | CN1602959A Nutrient product for enhancing immunity, preventing cancer and prolonging life of cancer patient and its preparing method |
| 04/06/2005 | CN1602892A Nutrient fluid for treating ultraviolet allergy |
| 04/06/2005 | CN1195493C Absorbable silicon implants containing beneficial substance |
| 04/06/2005 | CN1195485C Stable aqueous abrasive peroxide tooth whitening composition |
| 04/06/2005 | CN1195415C Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| 04/05/2005 | US6875752 Therapy for grampositive bacteria; bactericides |
| 04/05/2005 | US6875451 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 04/05/2005 | US6875018 Use of ozone for the treatment of root canals |
| 03/31/2005 | WO2005028032A1 Injectable therapeutic formulations |
| 03/31/2005 | WO2005028016A1 Chemoablation of tissue using biodegradable, solid salt dosage forms |
| 03/31/2005 | WO2005027988A2 Bone cement compositions having fiber-reinforcement and/or increased flowability |
| 03/31/2005 | WO2005027950A1 Eye nutritional supplement |
| 03/31/2005 | WO2005027948A1 Powdery composition for use as a laxative |
| 03/31/2005 | WO2005027907A1 Use of chk1 inhibitors to control cell proliferation |
| 03/31/2005 | WO2005027883A1 Gsk-3 beta inhibitors in the treatment of bone-related diseases |
| 03/31/2005 | WO2005027869A1 Use of oxygen in cosmetic or dermatological preparations |
| 03/31/2005 | WO2005027834A2 Partially hydrated hemostatic agent |
| 03/31/2005 | WO2005027808A1 Calcium zeolite hemostatic agent |
| 03/31/2005 | WO2005004883A3 Compound testing method |
| 03/31/2005 | WO2004111253A3 Polyvalent metal-substituted starch products |
| 03/31/2005 | WO2004098617A3 Controlled release composition containing a strontium salt |
| 03/31/2005 | WO2004076369A3 Antimicrobial active borosilicate glass |
| 03/31/2005 | WO2004064742A3 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 03/31/2005 | US20050070914 Use of vibration with polymeric bone cements |
| 03/31/2005 | US20050070595 Complex of trioxane with iron compound |
| 03/31/2005 | US20050069595 Antiinflammatory agents; mixture with glucocorticoids; respiratory system disorders; antiarthritic agents |
| 03/31/2005 | US20050069594 Pharmaceutical compositions and methods for the prevention of breast and ovarian cancer |
| 03/31/2005 | US20050069593 Synergistic mixtures; nutraceuticals |
| 03/31/2005 | US20050069592 Water-insoluble, antimicrobial silicate glass and use thereof |
| 03/31/2005 | US20050069583 Solid, digestable mixture of alginate, (bi)carbonate and polyol; gastrointestinal disorders |
| 03/31/2005 | DE10340845A1 Pharmazeutisches Kombinationspräparat, enthaltend Glycyrrhizinsäure, Zink und eine Verbindung, die eine Thiolgruppe oder eine zu dieser metabolisierbare Gruppe enthält A pharmaceutical combination preparation containing glycyrrhizic acid, zinc and a compound containing a thiol group or a metabolizable to this group |
| 03/31/2005 | DE10340277A1 Körperpflegemittel mit Silber-Agglomeraten Body care products with silver agglomerates |
| 03/31/2005 | DE10340276A1 Körperpflegemittel mit Silber und Zink Body care products with silver and zinc |
| 03/31/2005 | CA2539751A1 Bone cement compositions having fiber-reinforcement and/or increased flowability |
| 03/31/2005 | CA2539320A1 Use of chk1 inhibitors to control cell proliferation |
| 03/30/2005 | EP1518836A2 Substrate with photocatalytic coating |
| 03/30/2005 | EP1518560A1 Use of a gas for the manufacture of a diagnosing agent for diagnosing coronary perfusion |
| 03/30/2005 | EP1518559A1 Use of a gas for the manufacture of a monitoring agent for diagnosing passage through the intestinal tract or exocrine function of the pancreas |
| 03/30/2005 | EP1517681A1 Peritoneal dialysate containing taurine |
| 03/30/2005 | EP1517667A2 Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects |
| 03/30/2005 | EP1407047A4 METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN BASED ON GLUTATHIONE-S-TRANSFERASE Pi EXPRESSION |
| 03/30/2005 | EP0758890B1 Use of no scavengers, inhibitors or antagonists in the treatment of migraine |
| 03/30/2005 | CN1602360A Methods of increasing endogenous erythropoietin (EPO) |
| 03/30/2005 | CN1194744C Medicine for treating skin chap, and preparing method thereof |
| 03/30/2005 | CN1194734C Pill for treating hepatitis B |
| 03/30/2005 | CN1194731C Orally taken fracture setting Chinese medicine |
| 03/30/2005 | CN1194729C Externally used medicine for curing piles |
| 03/30/2005 | CN1194728C Pellet capable of curing infantile anorexia and convulsion |
| 03/30/2005 | CN1194727C Acne-treating composition |
| 03/30/2005 | CN1194720C Disinfecting liniment for treating skin disease |
| 03/30/2005 | CN1194710C Ointment for treating burn and scald and its preparing process |
| 03/30/2005 | CN1194673C Anti-Virus arosol inhalation medicine liquid |
| 03/30/2005 | CN1194668C Application of nano copper powder in preparation of immunopotentiator medicine |
| 03/29/2005 | US6872751 Composition and method for augmenting or restoring the production of fetal protein in patient in need thereof |
| 03/29/2005 | US6872408 Administering isotopically pure heavy water, carbonate or phosphate either containing deuterium and no hydrogen or hydrogen and no deuterium |
| 03/29/2005 | US6871805 For use in bath and body products/cosmetics; improved shelf-life and feel; free-flowing without anticaking agents |
| 03/29/2005 | CA2170772C Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 03/29/2005 | CA2099869C Particulates |
| 03/24/2005 | WO2005025589A1 Composition and method for facilitating bone healing |
| 03/24/2005 | WO2005025565A1 Microbicide composition comprising a minor groove binder optionally in combination with an anti-hiv compound and use thereof in the prevention of sexually transmitted diseases |
| 03/24/2005 | WO2005025501A2 Co-administration of polysaccharide with a chemotherapeutic agent for the treatment of cancer |
| 03/24/2005 | WO2005025450A2 Use of vibration with orthopedic cements |
| 03/24/2005 | WO2005018543A3 Silver-containing wound care device, composition therefor, and method of producing |
| 03/24/2005 | WO2005004942A3 Injectable composite for the magnetocytolysis of bone metastatic cells |
| 03/24/2005 | WO2005000324A3 Colloidal silver composition having antimicrobial properties |
| 03/24/2005 | WO2004098618A3 Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions |
| 03/24/2005 | WO2004091489A3 Topical blood pressure composition |
| 03/24/2005 | WO2004085098A3 Metallic nanoparticles as orthopedic biomaterial |
| 03/24/2005 | WO2003070185A3 Method for treating cellulite |
| 03/24/2005 | WO2003045973A8 Peptides with growth inhibitory action |
| 03/24/2005 | US20050065190 Comprehensive pharmacologic therapy for treatment of obesity including cysteine |
| 03/24/2005 | US20050065100 Concurrent administering regimen for controlling hypothalamus, pituary and adrenal glands with antiacne drug |
| 03/24/2005 | US20050064440 Using single nucleotide polymorphism in contactin-2 (CNTN-2) and kinesin-7 (CENP-E) genes as diagnostic indicators of cell proliferative disorders; antitumor agents; ribozymes and tumor treatment; RNA interference |
| 03/24/2005 | US20050064070 Beverage compositions for use in rehydration and nutrition during athletic exercise and methods of making same |
| 03/24/2005 | US20050064051 Oral Rinse |
| 03/24/2005 | US20050064047 Topical mixture of sulfur, selenium sulfide, and a carrier vehicle where a weight percent of sulfur is equal to or greater than that of the carrier vehicle; curing skin irritations, dermatitis, tinea versicolor or sun spots, seborrheic keratoses, foot fungus, e.g., athelete's foot, and tinea cruris |
| 03/24/2005 | US20050064046 Chemoablation of tissue using biodegradable, solid salt dosage forms |
| 03/24/2005 | US20050064045 Chemical ablation agent to cause tissue necrosis, and a biodegradable viscosity agent to form a highly viscous formulation for injection; prostatic ablation to treat benign prostatic hyperplasia |
| 03/24/2005 | US20050064044 Administering Glycogen synthase kinase 3 (GSK-3) inhibitors such as lithium chloride to treat osteoporosis for example; drug screening |
| 03/24/2005 | US20050064043 Ingesting a combination of dosage form of liquid, ingested in a series of sequential dosage: a first dose of bisacodyl;) a 2nd dose in a combination of bisacodyl, metoclopramide, a phosphorus compound and sodium, 3rd dose of phosphorus compounds and sodium, 4th dose of metoclopramide |
| 03/24/2005 | US20050064032 Dosage form, device, and methods of treatment |
| 03/24/2005 | US20050064020 Method for producing silver-containing antimicrobial fabric |
| 03/24/2005 | US20050064013 liquid beverage product for consumption by humans for restoring human growth hormone containing (A) pantothenic acid; (B) boron; (C) chromium; (D) copper; (E) isoleucine; (F) leucine;(G) valine; (H) choline; (I) arginine; and (J) water; dietary supplement for athletes and bodybuilders |
| 03/24/2005 | US20050063990 Compositons and methods for weight loss |
| 03/24/2005 | US20050063980 An alginate, a pectin and an antacid, such as sodium or potassium bicarbonate; gastrointestinal reflux disease |
| 03/24/2005 | US20050063966 Oxyfullerene hollow nanospheres and process for the preparation thereof |
| 03/24/2005 | US20050063922 Dental restorative materials |
| 03/24/2005 | US20050063903 Combined use of cruciferous indoles and chelators for the treatment of papilloma virus-related conditions |
| 03/24/2005 | US20050061678 Treatment of humans with colloidal silver composition |
| 03/23/2005 | EP1516639A1 Device in the treatment of pulmonary vasoconstriction and asthma |
| 03/23/2005 | EP1516542A1 Nutritional supplement to treat macular degeneration |